311 related articles for article (PubMed ID: 23789959)
1. Targeting CNS transporters for treatment of neurodegenerative diseases.
Jedlitschky G; Grube M; Mosyagin I; Kroemer HK; Vogelgesang S
Curr Pharm Des; 2014; 20(10):1523-33. PubMed ID: 23789959
[TBL] [Abstract][Full Text] [Related]
2. Membrane transporter proteins: a challenge for CNS drug development.
Girardin F
Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
[TBL] [Abstract][Full Text] [Related]
3. Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
Chaves C; Shawahna R; Jacob A; Scherrmann JM; Declèves X
Curr Pharm Des; 2014; 20(10):1450-62. PubMed ID: 23789951
[TBL] [Abstract][Full Text] [Related]
4. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules.
Harilal S; Jose J; Parambi DGT; Kumar R; Unnikrishnan MK; Uddin MS; Mathew GE; Pratap R; Marathakam A; Mathew B
Brain Res Bull; 2020 Jul; 160():121-140. PubMed ID: 32315731
[TBL] [Abstract][Full Text] [Related]
6. Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain.
Chaves C; Remiao F; Cisternino S; Decleves X
Curr Neuropharmacol; 2017 Nov; 15(8):1156-1173. PubMed ID: 28474563
[TBL] [Abstract][Full Text] [Related]
7. Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?
Sanchez-Covarrubias L; Slosky LM; Thompson BJ; Davis TP; Ronaldson PT
Curr Pharm Des; 2014; 20(10):1422-49. PubMed ID: 23789948
[TBL] [Abstract][Full Text] [Related]
8. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood-brain barrier.
Pinzón-Daza ML; Campia I; Kopecka J; Garzón R; Ghigo D; Riganti C
Curr Drug Metab; 2013 Jul; 14(6):625-40. PubMed ID: 23869808
[TBL] [Abstract][Full Text] [Related]
10. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
11. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
[TBL] [Abstract][Full Text] [Related]
12. ABC Transporters Are Key Players in Alzheimer's Disease.
Pereira CD; Martins F; Wiltfang J; da Cruz E Silva OAB; Rebelo S
J Alzheimers Dis; 2018; 61(2):463-485. PubMed ID: 29171999
[TBL] [Abstract][Full Text] [Related]
13. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
Shubbar MH; Penny JI
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
[TBL] [Abstract][Full Text] [Related]
14. Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?
Abdullahi W; Davis TP; Ronaldson PT
AAPS J; 2017 Jul; 19(4):931-939. PubMed ID: 28447295
[TBL] [Abstract][Full Text] [Related]
15. Targeting transporters for CNS drug delivery.
Ronaldson PT
Curr Pharm Des; 2014; 20(10):1419-21. PubMed ID: 23789947
[No Abstract] [Full Text] [Related]
16. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
17. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.
Miller DS
Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212
[TBL] [Abstract][Full Text] [Related]
18. Contributions of Drug Transporters to Blood-Brain Barriers.
Liu L; Liu X
Adv Exp Med Biol; 2019; 1141():407-466. PubMed ID: 31571171
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics.
Ronaldson PT; Davis TP
Expert Opin Drug Deliv; 2024; 21(1):71-89. PubMed ID: 38217410
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
Pardridge WM
Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
